In the competitive world of pharmaceutical and medical technology, market access represents the process of understanding the implications and the impact of a product in the healthcare market where a positive environment and communicating the ‘value’ of your product to the range of customers who influence uptake will make a big difference.

Only a fully integrated organisation can implement the processes, techniques and strategy required to get the right messages to the right stakeholders at the right time.

The U.S. pharma market is the largest pharmaceutical market worldwide, and continues to grow even though there are expected some structural changes in healthcare system due to evolving political landscape.
IMS Health has predicted that global spending will increase by 30% from 2015 to 2020, to US $1.4 trillion due in part to cheaper drugs, improved access and breakthrough innovations.

The two-days Market Access, Pricing and Reimbursement Global Congress 2017 Americas will provide a unique platform and a dynamic approach to key trends, methodologies and insights on market access, real world data, pricing, reimbursement, patient access and data collection than the current industry standard is anticipated.